Mark Gergen, Angel Investor

Mark J. Gergen is a seasoned strategic leader with extensive operational experience across biotech, pharmaceuticals, medical devices, and digital health. He has held executive leadership roles at Poseida Therapeutics, Mirati Therapeutics, and Amylin Pharmaceuticals, guiding companies through growth, scaling, and meaningful strategic exits. For nearly three decades, he has provided leadership to organizations as they execute on the promise of their technologies, leveraging his expertise in corporate strategy, operations, and business development. His career reflects a consistent focus on helping companies navigate complex markets and achieve long-term success. As an angel investor, Mark has supported ventures in biotechnology and healthcare innovation. His recent investment was in Breakthru Medicine, a Series A company, highlighting his interest in startups advancing transformative medical solutions.